Financhill
Back

Lixte Biotechnology Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
18

LIXT
Lixte Biotechnology Holdings

Last Price:
1.69
Seasonality Move:
2.1%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
18
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $1.52. The Score for LIXT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $1.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 40.08 Sell
Chaikin Money Flow: -1864 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.54 - 1.98) Sell
Bollinger Bands (100): (1.72 - 2.22) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.59 Sell
20-day SMA: 1.73 Sell
50-day SMA: 1.81 Sell
200-day SMA: 2.32 Sell
8-day EMA: 1.58 Sell
20-day EMA: 1.68 Sell
50-day EMA: 1.8 Sell
200-day EMA: 2.32 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):